Legal & General Group PLC Inhibrx, Inc. Transaction History

Legal & General Group PLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$32.76 - $39.56 $49,140 - $59,340	1,500 Added 7.79%	20,765 $725,000
Q4 2023 Feb 15, 2024	SELL	$14.5 - $38.0 $41,992 - $110,048	-2,896 Reduced 13.07%	19,265 $732,000
Q3 2023 Nov 14, 2023	SELL	$15.75 - $26.31 $4,126 - $6,893	-262 Reduced 1.17%	22,161 $406,000
Q2 2023 Aug 14, 2023	BUY	$16.96 - $27.82 $178,860 - $293,389	10,546 Added 88.79%	22,423 $582,000
Q1 2023 May 15, 2023	BUY	$18.45 - $27.14 $36,936 - $54,334	2,002 Added 20.27%	11,877 $224,000
Q4 2022 Feb 14, 2023	BUY	$20.18 - $33.33 $5,105 - $8,432	253 Added 2.63%	9,875 $243,000
Q3 2022 Nov 14, 2022	BUY	$11.58 - $24.73 $14,347 - $30,640	1,239 Added 14.78%	9,622 $173,000
Q2 2022 Aug 22, 2022	BUY	$8.52 - $25.26 $24,639 - $73,051	2,892 Added 52.67%	8,383 $95,000
Q1 2022 May 16, 2022	SELL	$19.89 - $43.18 $179 - $388	-9 Reduced 0.16%	5,491 $122,000
Q4 2021 Feb 14, 2022	BUY	$26.75 - $46.02 $1,284 - $2,208	48 Added 0.88%	5,500 $241,000
Q3 2021 Nov 15, 2021	BUY	$25.18 - $37.81 $45,928 - $68,965	1,824 Added 50.28%	5,452 $182,000
Q2 2021 Aug 12, 2021	BUY	$14.69 - $27.52 $30,760 - $57,626	2,094 Added 136.51%	3,628 $100,000
Q1 2021 May 17, 2021	BUY	$16.27 - $41.26 $10,998 - $27,891	676 Added 78.79%	1,534 $31,000
Q4 2020 Feb 12, 2021	BUY	$15.96 - $50.0 $13,693 - $42,900	858 New	858 $28,000

25.3K

Ticker INBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,057,700
Market Cap $617M
Description
Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.